We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBRV
5301
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-42
Closed -$7K
YGYI
5302
DELISTED
Youngevity International, Inc Common Stock
YGYI
-2,179
Closed -$3K
NFINU
5303
DELISTED
Netfin Acquisition Corp. Unit
NFINU
$0 ﹤0.01%
1
CBL
5304
DELISTED
CBL& Associates Properties, Inc.
CBL
-81,689
Closed -$22K
HCCOU
5305
DELISTED
Healthcare Merger Corp. Units
HCCOU
$0 ﹤0.01%
22
+18
+450% +$199
KNOW
5306
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
$0 ﹤0.01%
5
AXAS
5307
DELISTED
Abraxas Petroleum Corp
AXAS
-496
Closed -$2K
SAQNU
5308
DELISTED
Software Acquisition Group Inc. Unit
SAQNU
$0 ﹤0.01%
3
-97
-97% -$1.03K
INSUU
5309
DELISTED
Insurance Acquisition Corp. Unit
INSUU
$0 ﹤0.01%
21
-4
-16% -$55
LONE
5310
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
-64,349
Closed -$30K
ASFI
5311
DELISTED
Asta Funding Inc
ASFI
-1,956
Closed -$25K
PRNB
5312
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
-5,508
Closed -$329K
CNXM
5313
DELISTED
CNX Midstream Partners LP
CNXM
-233
Closed -$2K
CLUB
5314
DELISTED
Town Sports International Holdings, Inc.
CLUB
-33,732
Closed -$18K
MJCO
5315
DELISTED
Majesco
MJCO
-1,616
Closed -$13K
WUBA
5316
DELISTED
58.com Inc
WUBA
-1,417
Closed -$76K
SHLO
5317
DELISTED
Shiloh Industries Inc
SHLO
-13,573
Closed -$22K
PACK.WS
5318
DELISTED
One Madison Corporation Warrants, each whole warrant is exercisable for one Class A Common Stock at
PACK.WS
-24
Closed
LOGM
5319
DELISTED
LogMein, Inc.
LOGM
-17,735
Closed -$1.5M
FPAC.U
5320
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
-2
Closed
GSB
5321
DELISTED
GlobalSCAPE, Inc.
GSB
-6,371
Closed -$62K
BCTF
5322
DELISTED
Bancorp 34, Inc. Common Stock
BCTF
-97
Closed -$1K
BFYT
5323
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
-2,048
Closed -$42K
PACQU
5324
DELISTED
Pure Acquisition Corp. Unit
PACQU
-888
Closed -$9K
FSCT
5325
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
-15,418
Closed -$327K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.